Alzheimer's disease (AD) is a progressive neurodegenerative disease and the most
common cause of dementia in the elderly. Up to date, the available pharmacological options …

As the most prevalent form of dementia worldwide, Alzheimer's disease (AD) continues to be
a burden for patients and their families. In addition, with the global population of aged …

Alzheimer's disease (AD) is the most common cause of memory impairment and dementia in
the elderly. AD is pathologically characterized by extracellular deposits of beta-amyloid (Aβ) …

Alzheimer's disease (AD) is a progressive and ultimately fatal condition that causes
debilitating memory loss and extensive deterioration of cognitive and functional abilities …

Alzheimer's disease is the most common major neurocognitive disorder with substantial
social and economic impacts. This article is an update on current pharmacotherapy …

Alzheimer's disease (AD) is one the most prevalent multifactorial neurodegenerative
ailments of aging and is the leading cause of cognitive deficits with progressive impairment …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
abnormal accumulation of extracellular amyloid beta senile plaques and intracellular …

The increases in population ageing and growth are leading to a boosting in the number of
people living with dementia, Alzheimer's disease (AD) being the most common cause. In …

Alzheimer's disease is a devastating neurological disorder that affects more than 37 million
people worldwide. The economic burden of Alzheimer's disease is massive; in the United …

Alzheimer's disease (AD) is recognized as a major health hazard that mostly affects people
older than 60 years. AD is one of the biggest medical, economic, and social concerns to …